Document Detail

Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel.
MedLine Citation:
PMID:  22560668     Owner:  NLM     Status:  Publisher    
The vast majority of cells delivered into the heart by conventional means are lost within the first 24 h. Methods are needed to enhance cell retention, so as to minimize loss of precious material and maximize effectiveness of the therapy. We tested a cell-hydrogel delivery strategy. Cardiosphere-derived cells (CDCs) were grown from adult human cardiac biopsy specimens. In situ polymerizable hydrogels made of hyaluronan and porcine gelatin (Hystem(®)-C™) were formulated as a liquid at room temperature so as to gel within 20 min at 37 °C. CDC viability and migration were not compromised in Hystem-C™. Myocardial infarction was created in SCID mice and CDCs were injected intramyocardially in the infarct border zone. Real-time PCR revealed engraftment of CDCs delivered in Hystem-C™ was increased by nearly an order of magnitude. LVEF (left ventricular ejection fraction) deteriorated in the control (PBS only) group over the 3-week time course. Hystem-C™ alone or CDCs alone preserved LVEF relative to baseline, while CDCs delivered in Hystem-C™ resulted in a sizable boost in LVEF. Heart morphometry revealed the greatest attenuation of LV remodeling in the CDC + Hystem-C™ group. Histological analysis suggested cardiovascular differentiation of the CDCs in Hystem-C™. However, the majority of functional benefit is likely from paracrine mechanisms such as tissue preservation and neovascularization. A CDC/hydrogel formulation suitable for catheter-based intramyocardial injection exhibits superior engraftment and functional benefits relative to naked CDCs.
Ke Cheng; Agnieszka Blusztajn; Deliang Shen; Tao-Sheng Li; Baiming Sun; Giselle Galang; Thomas I Zarembinski; Glenn D Prestwich; Eduardo Marbán; Rachel R Smith; Linda Marbán
Related Documents :
16488358 - Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial ...
17379978 - The relationship between acute phase serum amyloid a (saa) protein concentrations and l...
9391858 - Mitral insufficiency as a complication of acute myocardial infarction and left ventricu...
9292328 - Effects of intracoronary diltiazem on certain hemostatic parameters during acute myocar...
3310938 - Thrombotic and bleeding complications of prosthetic heart valves.
12509688 - Critical review of unstable angina and non-st elevation myocardial infarction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-2
Journal Detail:
Title:  Biomaterials     Volume:  -     ISSN:  1878-5905     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
The Cedars-Sinai Heart Institute, Los Angeles, CA 90048, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide n...
Next Document:  The role of endothelial cells in the retinal stem and progenitor cell niche within a 3D engineered h...